"Penny Stock 101 spam or worse subway to jail/
Your investment has returned 60% loss for 5 years. Therefore, your statement is paradoxical to understanding. Eman is selling stock at ATM equity " ATM equity raise in September. Through the end of the quarter, the company raised by $19,000 " because, reason recognizes the story isn't worth buying I E Vuzix/Intel buys in and Oculus Facebook buys the perceived on ramp to VR/AR.
Aside, from card/platform guys deciding a standard for mobile commerce, fraud is one of the deterrents to mobile payments gaining momentum.
Of-course, you can't govern like a free man, because your emotional and cannot coincide with me. Therefore, you must attack me like in Plato's Allegory of the Cave. And yet, many here have tried to liberate you and the daily posters from drinking hemlock. This companionship (club EMAN) is not good if its inferior to the truth. Lastly, knowledge is mostly genetic and the privilege of profiting from stocks exists from becoming an accurate thinker. Instead, you are guided and deprived by the common safety of opinions.
Ask your self- why other companies can garner/attract funding Oculus/VUZIX and not EMAN. Clearly, their technology isn't seen as being exceptional nor available at present. Additionally, AS (a smart guy) is a lousy at executing on goals. Finally, you should look at their lack of sales capabilities. If the stuff is the best, then Eskimo's buy ice cubes in the marketplace.
Everybody on this board was warned about EMAN. I full boated 65,000 shares till I exhausted of management chronically missing goals and patenting shortcomings with excuses. The key to investing is finding good Management: Rodney Sachs (MNST), Michael Minogue (ABMD), Jeff Bezos (AMZN) ,and others. The superior men are sparing in their words and profuse in their deeds.
Of course- Jerry left for Google, Paul left for some sleep and Dan will get business from the company he exited. I guess, the collapse of reason pump statement could be: "EMAN to supply the 4K displays to VUZI".
They need to do a promotion or even investor relations push that states: In lung cancer our sensitivity for detection is this vs standard of care and mention competitor products.